zurück zur Startseite
Zentrale Tel.: 06221-560

Curriculum Vitae

Prof. Dr. rer. nat. Ingrid Herr




Director Opens external link in new windowSection Surgical Research

Team Leader Opens external link in new windowMolecular OncoSurgery  



Section Surgical Research

Im Neuenheimer Feld 365

69120 Heidelberg, Germany

Opens window for sending emaileMail






Studies in Biology, University of Ulm, Germany, Diploma degree


Diploma thesis, University of Ulm, Department of Biochemistry,

Supervisor: Prof. M. Montenarh, Topic: "Expression of p53 in a

rabbit reticulocyte- and bacculovirus system"


Doctoral work with degree "Dr. rer. nat.", Forschungszentrum

Karlsruhe, Germany, supervisors: Prof. P. Herrlich, Prof. P. Angel

Topic: "Transcriptional control of the proto-oncogene c-jun" 


Postdoctoral training, DKFZ Heidelberg, Clinical Cooperation Unit

"Molecular Oncology/Pediatrics", Leader: Prof. K.-M. Debatin


Deputy leader of the Clinical Cooperation Unit

"Molecular Oncology/Pediatrics"


Habilitation and Venia Legendi in Experimental Medicine, 

Medical Faculty Ulm, Germany


Leader of the DKFZ Clinical Cooperation Group

“Molecular UroOncology”, University Surgery Clinic + DKFZ


APL-Professorship (20.10.2005), Medical Faculty Ulm

seit 2006

Leader of the DKFZ Clinical Cooperation Group

“Molecular OncoSurgery”, University Surgery Clinic + DKFZ



Habilitation Medical Faculty Heidelberg (16.5.2012),

APL-Professorship, Medical Faculty Heidelberg (28.01.2013)


Director, Section “Surgical Research” (13.11.2014), University Surgery Clinic Heidelberg


Honors, Awards

1997Franziska-Kolb-Award for Leukemia Research, University of Ulm
2007Best Scientific Project, 39. Meeting European Pancreas Club

Call to an Associate Professorship position, University of Göttingen, Germany

2012Sebastian-Kneipp-Award, Sebastian-Kneipp-Foundation


Scientific publications

Total-IF2015: 684

95 original articles (PubMed-listed), 12 first-, 43 last-authorships

17 review articles (PubMed-listed)

13 review articles not PubMed-listed

30 book chapters

7 patents, 2 licence agreements


Hirsch-Index: 39


The best first- and last-author manuscripts are published in: 


Nature Medicine, Lancet Oncology, GUT, Leukemia, Blood, Hepatology, EMBO Journal, Cancer Research, Clinical Cancer Research, Cell Death and Differentiation, Oncogene, Journal of Pathology, Molecular Therapy, Cancer Letters, International Journal of Cancer, British Journal of Cancer, ALTEX, Oncotarget and others.

Opens external link in new windowPublications



Society Czerny, Medical Faculty Heidelberg

Research Commission, Medical Faculty Heidelberg

International Journal of Oncology

Molecular and Clinical Oncology



for peer-reviewed journals including The Lancet, Blood, Gastroenterology, Gut, Cancer Research, Journal of Pathology and others

for research foundations including German Research Society (DFG) and others


Research field

  • Mechanisms of therapy resistance in pancreatic cancer stem cells with focus to:
  • Glucocorticoids 
  • Glucose metabolism
  • Autophagy
  • Therapeutic targeting by bioactive plant-derived substances 
  • Gap junctional intercellular communication
  • miRNA signaling


  • Medical Faculty Ulm 2000-2011: Biochemistry-practice, 45 hours summer semester
  • Medical Faculty Heidelberg, Sozietät Czerny: since 2´2009 until today: stem cell course, 32 hours winter semester 
  • Medical Faculty Heidelberg, DKFZ-teaching: since 2005 until today: stem cell seminar, 16 hours summer and winter semester each
  • Faculty of Biosciences Heidelberg, DKFZ-Major Cancer Master-studies: since 2013 until today: Tumorxenotransplantation on fertilized chick eggs as animal replacement method, 32 hours summer semester


Education of students

  • Supervised and completed Diploma-/Bachelor-/Master thesis: 15
  • Supervised and completed PhD and MD thesis: 18
  • Supervised, ongoing PhD and MD thesis: 10
Select languageSelect languageSelect language
Print Diese Seite per E-Mail weiterempfehlen



"Doubt is the beginning of the science. Who doubts nothing will not consider anything. Who considers nothing will not discover anything. Who discovers nothing is blind and will remain blind." 

Teilhard de Chardin (1881-1955), french theologian and philosopher